Glomerulonephritis describes inflammatory injury involving the glomeruli. Patients may present with hematuria, proteinuria, hypertension, edema, reduced kidney function, or a rapidly progressive nephritic syndrome.
The most efficient approach is not to memorize every disease individually. Begin with the urine sediment, complement level, serology, systemic manifestations, and speed of kidney function decline.
Recognize The Nephritic Pattern
Common findings include:
- Glomerular hematuria
- Dysmorphic red blood cells
- Red blood cell casts
- Variable proteinuria
- Hypertension
- Edema
- Increased creatinine
The absence of a red blood cell cast does not exclude glomerulonephritis. Urine microscopy quality and timing matter.
Determine The Clinical Urgency
Rapidly progressive glomerulonephritis may cause a substantial decline in kidney function over days to weeks.
Urgent features include:
- Rapidly rising creatinine
- Oliguria
- Hyperkalemia
- Severe acid-base disturbance
- Pulmonary hemorrhage
- Severe hypertension
- Fluid overload
Serologic testing and kidney biopsy should be coordinated quickly when organ-threatening disease is suspected.
Divide The Differential By Complement
Low Complement
Important possibilities include:
- Lupus nephritis
- Infection-related glomerulonephritis
- Cryoglobulinemic glomerulonephritis
- Immune-complex membranoproliferative patterns
- Complement-mediated glomerulopathy
Low complement suggests consumption or dysregulation but does not establish a single diagnosis.
Normal Complement
Important possibilities include:
- IgA nephropathy
- ANCA-associated vasculitis
- Anti-GBM disease
- Alport syndrome
- Thin basement membrane disease
Complement is a sorting tool, not a final answer.
Use Serology Purposefully
ANA And Anti-Double-Stranded DNA
These findings may support systemic lupus erythematosus. Low complement, proteinuria, hematuria, and active sediment increase concern for lupus nephritis.
ANCA
PR3-ANCA and MPO-ANCA may support ANCA-associated vasculitis. The clinical pattern may include glomerulonephritis, pulmonary capillaritis, upper-airway disease, neuropathy, skin lesions, or eosinophilic disease.
ANCA results must be interpreted within the clinical context.
Anti-GBM Antibodies
Anti-GBM disease may present with rapidly progressive glomerulonephritis, pulmonary hemorrhage, or both. Because kidney function can deteriorate rapidly, evaluation and treatment are time-sensitive.
Cryoglobulins
Cryoglobulinemic disease may cause glomerulonephritis, purpura, neuropathy, arthralgia, and low complement. Evaluation should include possible infectious, autoimmune, and lymphoproliferative causes.
Infection Testing
Depending on the presentation, testing may include hepatitis B, hepatitis C, HIV, blood cultures, or evaluation for another active infection.
Recognize Pulmonary-Renal Syndromes
The combination of glomerulonephritis and diffuse alveolar hemorrhage is an emergency.
Important causes include:
- ANCA-associated vasculitis
- Anti-GBM disease
- Systemic lupus erythematosus
- Other severe immune-complex disorders
Hemoptysis may be absent. Falling hemoglobin, new pulmonary infiltrates, hypoxemia, and active urine sediment should raise concern.
Understand The Role Of Kidney Biopsy
Serology suggests a mechanism. Biopsy can define:
- The pattern of injury
- Disease activity
- Chronic irreversible damage
- Immune deposits
- Prognostic features
- Treatment implications
Light microscopy, immunofluorescence, and electron microscopy provide complementary information.
Treatment should not necessarily be delayed when life-threatening pulmonary or renal involvement is strongly suspected.
High-Yield Framework
When glomerulonephritis is suspected:
- Confirm the nephritic urine pattern.
- Determine how quickly kidney function is changing.
- Check complement.
- Order serology based on the clinical pattern.
- Search for pulmonary and systemic involvement.
- Exclude infection and important mimics.
- Obtain a kidney biopsy when appropriate.
- Begin urgent treatment when organs are threatened.
The laboratory panel does not replace clinical reasoning. Complement and antibodies are most useful when they are connected to the urine sediment, organ pattern, and disease timeline.
References
- Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International. 2021.
- Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for ANCA-Associated Vasculitis.

